Lamei Guo is a joint graduate student at the National Center for Nanoscience and Technology (advisors: Prof. Hao Wang and Assoc. Prof. Yu Yi). She started her M.S. degree at the School of Environmental Science and Safety Engineering, Tianjin University of Technology in 2021 (advisor: Prof. Jinjun Yang) and enrolled in the National Center for Nanoscience and Technology in 2022. Her research is focused on the high-throughput screening of in vivo self-assembled selenopeptide nanomaterials for cancer immunotherapy and anti-inflammatory diseases.
Jinjun Yang is a Professor at the School of Environmental Science and Safety Engineering, at Tianjin University of Technology. He completed his Ph.D. studies at the Tokyo Institute of Technology, was a Visiting Scholar/Guest Researcher at the University of Tokyo, and was a Visiting Scholar at Osaka University. He won the second-class prize of the Tianjin Scientific and Technological Progress Prize in 2017. His research areas include 1. flame retardant, flame suppression, and fireproof and high-temperature resistant materials; 2. bio-based and biodegradable materials; 3. adsorption and separation materials; and 4. photocatalytic materials and new energy sources.
Hao Wang is a professor and director of the Laboratory for Biological Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology (NCNST). He obtained his B.S. and Ph.D. degrees at the Department of Chemistry, Nankai University, in 2000 and 2005, respectively. He was an Alexander von Humboldt (AvH) Fellow at the Universität Würzburg (2005–2007) and a Postdoctoral Fellow at the Department of Molecular and Medical Pharmacology, UCLA (2007–2010). He started his independent career as a “100 Talents Program of the CAS” professor in 2011 at NCNST. His current research interests are to (i) develop “in vivo self-assembly” technology in physiological/pathological conditions; (ii) study their bio-effect and further regulate biological behavior; and (iii) explore self-assembled biomaterials for bioimaging, drug delivery, immunotherapy, etc. He envisions that the modular molecular assembly strategy and modern in vivo diagnostics/therapeutics represent an important paradigm shift for biomaterial development, drug discovery, and clinical patient management. He serves as the associate editor of ACS Biomaterials Science and Engineering, handling editor of Nano Today, and the editorial board of ACS Applied Bio Materials, Chinese Chemical Letters. He is the principal investigator of the National Key Research and Development Program of China, the National Science Fund for Distinguished Young Scholars, and the National High-Level Talents Special Support Program.
Yu Yi is an Associate Professor at the CAS Key Laboratory for Biological Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology. He received his B.S. and M.S. degrees at the Department of Chemistry, Tsinghua University in 2010 and 2013, respectively, and obtained his Ph.D. degree in bioengineering at the University of Tokyo in 2016. He was a postdoctoral fellow at the University of Tokyo (2016–2017) and came to the National Center for Nanoscience and Technology as an Associate Professor in 2018. He serves as the youth editor of Nano Research, Exploration, and Journal of China Pharmaceutical University. His research areas include selenopeptide functional materials, in vivo supramolecular assemblies, and single-atom biocatalysis.